Global Combined Hormonal Contraceptives Market Growth 2023-2029

Global Combined Hormonal Contraceptives Market Growth 2023-2029

Combined hormonal contraceptives are used to prevent pregnancies. They are also used in the treatment of acne vulgaris, endometriosis, polycystic ovarian syndrome, and irregular menstrual flow by blocking ovulation. These products are widely used by women of aged between 15 and 49 years.

LPI (LP Information)' newest research report, the “Combined Hormonal Contraceptives Industry Forecast” looks at past sales and reviews total world Combined Hormonal Contraceptives sales in 2022, providing a comprehensive analysis by region and market sector of projected Combined Hormonal Contraceptives sales for 2023 through 2029. With Combined Hormonal Contraceptives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Combined Hormonal Contraceptives industry.

This Insight Report provides a comprehensive analysis of the global Combined Hormonal Contraceptives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Combined Hormonal Contraceptives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Combined Hormonal Contraceptives market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Combined Hormonal Contraceptives and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Combined Hormonal Contraceptives.

The global Combined Hormonal Contraceptives market size is projected to grow from US$ 17400 million in 2022 to US$ 22000 million in 2029; it is expected to grow at a CAGR of 22000 from 2023 to 2029.

United States market for Combined Hormonal Contraceptives is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Combined Hormonal Contraceptives is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Combined Hormonal Contraceptives is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Combined Hormonal Contraceptives players cover Actavis, Agile Therapeutics, Allergan, Bayer, Teva Pharmaceutical Industries, ANI Pharmaceuticals, Ortho-McNeil-Janssen Pharmaceuticals, Noven Pharmaceuticals and Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Combined Hormonal Contraceptives market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
15-24 years
25-34 years
35-44 years
Above 44 years

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Actavis
Agile Therapeutics
Allergan
Bayer
Teva Pharmaceutical Industries
ANI Pharmaceuticals
Ortho-McNeil-Janssen Pharmaceuticals
Noven Pharmaceuticals
Johnson & Johnson
Mylan

Key Questions Addressed in this Report

What is the 10-year outlook for the global Combined Hormonal Contraceptives market?

What factors are driving Combined Hormonal Contraceptives market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Combined Hormonal Contraceptives market opportunities vary by end market size?

How does Combined Hormonal Contraceptives break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.